Cargando…

Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1

SIMPLE SUMMARY: PD-L1 plays a crucial role in the immune responses against cancer. Only around 30% of cancer patients respond to an anti-PD-L1 immune checkpoint inhibitor therapy. Noninvasive molecular imaging techniques such as positron emission tomography (PET) would allow identification of patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krutzek, Fabian, Donat, Cornelius K., Ullrich, Martin, Zarschler, Kristof, Ludik, Marie-Charlotte, Feldmann, Anja, Loureiro, Liliana R., Kopka, Klaus, Stadlbauer, Sven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177516/ https://www.ncbi.nlm.nih.gov/pubmed/37174103 http://dx.doi.org/10.3390/cancers15092638

Ejemplares similares

Development of Radiotracers for Imaging of the PD-1/PD-L1 Axis
por: Krutzek, Fabian, et al.
Publicado: (2022)

Exploring Hydrophilic PD-L1 Radiotracers Utilizing Phosphonic Acids: Insights into Unforeseen Pharmacokinetics
por: Krutzek, Fabian, et al.
Publicado: (2023)

Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study
por: Reissig, Falco, et al.
Publicado: (2021)

Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin
por: Reissig, Falco, et al.
Publicado: (2022)

Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents
por: Kanagasundaram, Thines, et al.
Publicado: (2021)

Sub‐10 nm Radiolabeled Barium Sulfate Nanoparticles as Carriers for Theranostic Applications and Targeted Alpha Therapy
por: Reissig, Falco, et al.
Publicado: (2020)

Translating Molecules into Imaging—The Development of New PET Tracers for Patients with Melanoma
por: Vercellino, Laetitia, et al.
Publicado: (2022)

The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging
por: Eder, Ann-Christin, et al.
Publicado: (2021)

Development and Validation of a GMP-Compliant High-Pressure Liquid Chromatography Method for the Determination of the Chemical and Radiochemical Purity of [(18)F]PSMA-1007, a PET Tracer for the Imaging of Prostate Cancer
por: Katzschmann, Ines, et al.
Publicado: (2021)

Novel Preclinical and Radiopharmaceutical Aspects of [(68)Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
por: Eder, Matthias, et al.
Publicado: (2014)

The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II
por: Smits, Anja, et al.
Publicado: (2011)

A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR
por: Arndt, Claudia, et al.
Publicado: (2019)

PET Tracers for Clinical Imaging of Breast Cancer
por: Peñuelas, Iván, et al.
Publicado: (2012)

Microfluidics for Synthesis of Peptide-Based PET Tracers
por: Liu, Yang, et al.
Publicado: (2013)

Advanced Tracers in PET Imaging of Cardiovascular Disease
por: Li, Yesen, et al.
Publicado: (2014)

Stroke detection with 3 different PET tracers
por: Dundar, Ayca, et al.
Publicado: (2019)

Emerging PET Tracers in Cardiac Molecular Imaging
por: Singh, Shashi Bhushan, et al.
Publicado: (2023)

Imidazoline-I2 PET Tracers in Neuroimaging
por: Parker, Christine A., et al.
Publicado: (2023)

A new F-18 labeled PET tracer for fatty acid imaging
por: Demeure, Fabian, et al.
Publicado: (2014)

Efforts toward PET-Activatable Red-Shifted Silicon Rhodamines and Silicon Pyronine Dyes
por: Kramer, Carsten Sven, et al.
Publicado: (2023)

Erratum to: A new F-18 labeled PET tracer for fatty acid imaging
por: Demeure, Fabian, et al.
Publicado: (2014)

PET tracer development—a tale of mice and men
por: Hicks, Rodney J, et al.
Publicado: (2006)

Beyond FDG: novel PET tracers for cancer imaging
por: Hicks, Rodney J
Publicado: (2003)

Microfluidics: A Groundbreaking Technology for PET Tracer Production?
por: Rensch, Christian, et al.
Publicado: (2013)

Application of PET Tracers in Molecular Imaging for Breast Cancer
por: Boers, Jorianne, et al.
Publicado: (2020)

Protocols for Dual Tracer PET/SPECT Preclinical Imaging
por: Blower, Julia E., et al.
Publicado: (2020)

Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET
por: Huang, Yuan, et al.
Publicado: (2021)

Potential PET tracers for imaging of tumor-associated macrophages
por: Fernandes, Bruna, et al.
Publicado: (2022)

Update on PET Tracer Development for Muscarinic Acetylcholine Receptors
por: Ozenil, Marius, et al.
Publicado: (2021)

PET Tracers for Imaging Cardiac Function in Cardio-oncology
por: Kelly, James M., et al.
Publicado: (2022)

Breast PET/MRI Hybrid Imaging and Targeted Tracers
por: Romeo, Valeria, et al.
Publicado: (2022)

A Promising PET Tracer for Imaging of α(7) Nicotinic Acetylcholine Receptors in the Brain: Design, Synthesis, and in Vivo Evaluation of a Dibenzothiophene-Based Radioligand
por: Teodoro, Rodrigo, et al.
Publicado: (2015)

Prognostic implications of dual tracer PET/CT: PSMA ligand and [(18)F]FDG PET/CT in patients undergoing [(177)Lu]PSMA radioligand therapy
por: Michalski, Kerstin, et al.
Publicado: (2020)

Plasma radio-metabolite analysis of PET tracers for dynamic PET imaging: TLC and autoradiography
por: Li, Fiona, et al.
Publicado: (2020)

PET Imaging in Cardiac Sarcoidosis: A Narrative Review with Focus on Novel PET Tracers
por: Saric, Petar, et al.
Publicado: (2021)

Methodology for Quantitative Rapid Multi-Tracer PET Tumor Characterizations
por: Kadrmas, Dan J., et al.
Publicado: (2013)

On the Road towards Small-Molecule Programmed Cell Death 1 Ligand 1 Positron Emission Tomography Tracers: A Ligand-Based Drug Design Approach
por: Bamminger, Karsten, et al.
Publicado: (2023)

Radiation dosimetry of the α(4)β(2) nicotinic receptor ligand (+)-[(18)F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results
por: Kranz, Mathias, et al.
Publicado: (2016)

Pharmacological characterization of mutant huntingtin aggregate-directed PET imaging tracer candidates
por: Herrmann, Frank, et al.
Publicado: (2021)

Interpol review papers special edition preface
por: Ludik, Paul S.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_48a31i9ghsqppamsh23uahljg8